A

Atara Biotherapeutics
D

ATRA

12.080
USD
0.69
(6.06%)
Market Closed
Volume
7,745
EPS
-17
Div Yield
-
P/E
-0
Market Cap
69,577,780
OverviewSignalsIdeasNews
Related Instruments
    A
    ARRY
    0.48000
    (8.54%)
    6.10000 USD
    B
    BLUE
    -0.87500
    (-10.31%)
    7.61500 USD
    B
    BMRN
    0.560
    (0.85%)
    66.240 USD
    C
    CRSP
    -0.220
    (-0.54%)
    40.500 USD
    E
    EDIT
    -0.06000
    (-4.55%)
    1.26000 USD
    I
    INCY
    0.950
    (1.38%)
    69.860 USD
    L
    LGND
    -1.270
    (-1.11%)
    113.530 USD
    M
    MRTX
    0
    (0%)
    0.000000 USD
    More
News

Title: Atara Biotherapeutics Inc.

Sector: Healthcare
Industry: Biotechnology
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).